Suchergebnisse - "Borsani, Oscar"

PubPharm (40)

1

Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms

enthalten in: Haematologica | 2024

von Borsani, O. | Jäger, R. | Pietra, D. | +4

2

Germline MPL mutations may be a rare cause of "triple-negative" thrombocytosis

enthalten in: Experimental hematology | 2024

von Borsani, O. | Pietra, D. | Casetti, I. | +7

3

Incidence of blast phase in myelofibrosis according to anemia severity

enthalten in: EJHaem | 2023

von Mora, B. | Maffioli, M. | Rumi, E. | +22

4

Primary Budd-Chiari Syndrome

enthalten in: The New England journal of medicine | 2023

von Borsani, O. | Pietra, D. | Rumi, E.

CommentOn: N Engl J Med. 2023 Apr 6;388(14):1307-1316. - PMID 37018494

5

Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2023

von Zavaglio, F. | Vitello, D. | Bergami, F. | +8

6

Wandering Spleen : An Unusual Cause of Recurrent Abdominal Pain

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Borsani, O. | Braschi-Amirfarzan, M. | Boveri, E. | +1

7

Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver

enthalten in: Cancer medicine | 2023

von Bonometti, A. | Borsani, O. | Rumi, E. | +5

8

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting : An Italian MYNERVA Project

enthalten in: Cancer medicine | 2023

von Coltro, G. | Sant'Antonio, E. | Palumbo, G. | +18

9

SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Borsani, O. | Ferretti, V. | Casetti, I. | +6

10

Arginase‐1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver

enthalten in: Cancer Medicine | 2023

von Bonometti, A. | Borsani, O. | Rumi, E. | +5